Jiangsu Hengrui Medicine
600276.SS
#467
Rank
โ‚น3.711 T
Marketcap
โ‚น581.86
Share price
-1.00%
Change (1 day)
5.01%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น1.05 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is โ‚น1.05 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚น16.31 B821.41%
2021-12-31โ‚น1.77 B
2015-12-31โ‚น0.10 B0.48%
2014-12-31โ‚น0.10 B-49.87%
2013-12-31โ‚น0.20 B132.49%
2012-12-31โ‚น87.81 M-47.83%
2011-12-31โ‚น0.16 B24.2%
2010-12-31โ‚น0.13 B99.52%
2009-12-31โ‚น67.93 M
2007-12-31โ‚น0.32 B18.53%
2006-12-31โ‚น0.27 B1.73%
2005-12-31โ‚น0.26 B-48.38%
2004-12-31โ‚น0.51 B-75.22%
2003-12-31โ‚น2.09 B40.86%
2002-12-31โ‚น1.48 B1.19%
2001-12-31โ‚น1.46 B42.56%
2000-12-31โ‚น1.03 B-5.45%
1999-12-31โ‚น1.08 B47.44%
1998-12-31โ‚น0.73 B19.26%
1997-12-31โ‚น0.61 B